Previous Article | Next Article ![]()
Journal of Virology, June 1999, p. 4890-4898, Vol. 73, No. 6
Department of Immunology and Microbiology and
Karmanos Cancer Institute, Wayne State University, Detroit,
Michigan 48201,1 and Biotherapies, Inc.,
Ann Arbor, Michigan 481052
Received 17 November 1998/Accepted 17 March 1999
We previously showed that the 93-bp region between the enhancer and
promoter (named DEN for downstream of enhancer) of the long terminal
repeat (LTR) of the MCF13 murine leukemia virus is an important
determinant of the ability of this virus to induce thymic lymphoma. In
this study we observed that DEN plays a role in the regulation of virus
replication in the thymus during the preleukemic period. A NF-
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Sequences between the Enhancer and Promoter in the Long Terminal
Repeat Affect Murine Leukemia Virus Pathogenicity and Replication
in the Thymus
B site
in the DEN region partially contributes to the effect of DEN on both
lymphomagenicity and virus replication. To further study the effects of
DEN and the NF-
B site on viral pathogenicity during the preleukemic
period, we examined replication of wild-type and mutant viruses with a
deletion of the NF-
B site or the entire DEN region in the thymus.
Thymic lymphocytes which were infected with wild-type and mutant
viruses were predominantly the CD3
CD4+
CD8+ and CD3+ CD4+ CD8+
cells. The increase in infection by wild-type virus and both mutant
viruses of these two subpopulations during the preleukemic period
ranged from 9- to 84-fold, depending upon the time point and virus. The
major difference between the wild-type and both mutant viruses was the
lower rate and lower level of mutant virus replication in these thymic
subpopulations. Significant differences in replication between
wild-type and both mutant viruses were seen in the CD3
CD4+ CD8+ and CD3
CD4
CD8
subpopulations, suggesting that
these thymic cell types are important targets for viral transformation.
*
Corresponding author. Mailing address: Department of
Immunology and Microbiology and Karmanos Cancer Institute, Wayne State University, 540 E. Canfield Ave., Detroit, MI 48201. Phone: (313) 577-1571. Fax: (313) 577-1155. E-mail:
fyoshi{at}med.wayne.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|